Evidence map›Paper›PMID 32582763›Full record

ArticleFrontiers in molecular biosciences2020

Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and

Aboubakr Haredi Abdelmonsef, Mahmoud Eldeeb Mohamed, Mohamed El-Naggar, Hussain Temairk, Ahmed Mohamed Mosallam

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Design, synthetic approach,RSC advances · 2022
    Article
  11. Article
  12. Synthesis, characterization,RSC advances · 2022
    Article
  13. Article
  14. Article
  15. Antibiotics (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Synthesis, Molecular Docking Analysis andFrontiers in molecular biosciences · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Aboubakr Haredi AbdelmonsefChemistry Department, Faculty of Science, South Valley University, Qena, Egypt.
Mahmoud Eldeeb MohamedChemistry Department, Faculty of Science, South Valley University, Qena, Egypt.
Mohamed El-NaggarChemistry Department, Faculty of Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Hussain TemairkChemistry Department, Faculty of Science, South Valley University, Qena, Egypt.
Ahmed Mohamed MosallamChemistry Department, Faculty of Science, South Valley University, Qena, Egypt.
South Valley University · EGUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research explores the synthesis of a series of novel hybrid quinazolin-2,4-dione analogs bearing acetyl/amide bridged-nitrogen heterocyclic moieties such as azetidinone, pyrrole, oxazole, oxadiazole, thiazole, pyrazole, and thiazolidine scaffolds

Indexed as

docking studyhybrid moleculesmalariaN-heterocyclic moietiespfDHODHquinazolin-2,4-dione

Identifiers

PMID32582763
PMCPMC7291371
OpenAlexW3033715310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.